Skip to main content
SpringerLink
Log in

Attention-deficit hyperactivity disorder: a view from the USA

  • Viewpoint
  • Published:

From Nature Clinical Practice Neurology

View current issue Sign up to alerts

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. American Psychiatric Association (1980) Diagnostic and Statistical Manual of Mental Disorders, edn 3. Washington, DC: American Psychiatric Press

  2. Rutter M et al. (1970) A Neuropsychiatric Study in Childhood. London: Spastics International Medical Publications/Heinemann

    Google Scholar 

  3. Timimi S and Taylor E (2004) ADHD is best understood as a cultural construct. Br J Psychiatry 184: 8–9

    Article  Google Scholar 

  4. World Health Organization (1993) The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva: World Health Organization

  5. Polanczyk G et al. (2007) The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J. Psychiatry 164: 942–948

    Article  Google Scholar 

  6. Visser S et al. (2007) National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder. Pediatrics 119: S99–S106

    Article  Google Scholar 

  7. Ford T et al. (2003) The British Child and Adolescent Mental Health Survey 1999: the prevalence of DSM-IV disorders. J Amer Acad Child Adolesc Psychiatry 42: 1203–1211

    Article  Google Scholar 

  8. American Academy of Child and Adolescent Psychiatry (2007) Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 46: 894–921

  9. American Academy of Pediatrics: Clinical Practice Guideline (2001) Treatment of the school-age child with attention-deficit/hyperactivity disorder. Pediatrics 108: 1033–1044

  10. The MTA Cooperative Group (1999) A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 56: 1073–1086

Download references

Author information

Authors and Affiliations

  1. MA Riddle is Professor of Psychiatry and Pediatrics and Director of the Division of Child and Adolescent Psychiatry at the Johns Hopkins University School of Medicine, Division of Child and Adolescent Psychiatry, and Vice President for Psychiatric Sciences at Kennedy Krieger Institute for developmental disabilities, and JT Walkup is an Associate Professor of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.,

    Mark A Riddle & John T Walkup

Authors
  1. Mark A Riddle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John T Walkup
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mark A Riddle.

Ethics declarations

Competing interests

Mark A Riddle is a consultant for Jazz Pharmaceuticals, Johnson & Johnson, and Shire.

John T Walkup is a consultant for GlaxoSmithKline and Eli Lilly, and has received grant/research support from Pfizer.

About this article

Cite this article

Riddle, M., Walkup, J. Attention-deficit hyperactivity disorder: a view from the USA. Nat Rev Neurol 4, 118–119 (2008). https://doi.org/10.1038/ncpneuro0732

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneuro0732

  • Springer Nature Limited

Search

Navigation